Using a mouse model of streptococcal infection, we previously demonstrated that kallistatin gene transfer reduced bacteremia, skin and liver damage, and mortality, as well as decreased inflammatory cell numbers and inflammatory cytokine levels at local infection sites [14]. This evidence concerns the gene SERPINA4 and bacterial infectious disease with sepsis.